Morgan Stanley Maintains Overweight on Synopsys, Raises Price Target to $574
Morgan Stanley analyst Lee Simpson maintains Synopsys (NASDAQ:SNPS) with a Overweight and raises the price target from $500 to $574.
Stocks · News reference
TetraMem Utilizes Synopsys Cloud FlexEDA for 12nm AI SoC Tapeout
TetraMem successfully taped out its MLX300 AI system-on-chip using Synopsys' cloud-enabled EDA solutions, marking a milestone in analog in-memory computing.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of software companies are trading lower amid a rotation out of technology and AI-related stocks. Rising inflation concerns and elevated oil prices are fueling expectations for further Fed tightening, while elevated borrowing costs could weigh on demand, valuations and debt metrics.
The Stock Market Will Look Completely Different by 2030. This Is the Stock I'm Buying Before It Does.
As AI adoption shifts from infrastructure building to productivity gains, Synopsys emerges as a potential winner by providing chip design software and IP. The company targets $17 billion in revenue and $8.5 billion in operating income by fiscal 2030, but valuation risks could limit shareholder returns despite strong earnings growth projections.